Geodon
FDA says three atypical antipsychotic medications may be effective in children, but carry risks.
Monday, June 8th, 2009The Wall Street Journal (6/5, Dooren) reported that on June 5, staff from the Food and Drug Administration (FDA) said that three medications “currently approved to treat bipolar disorder and schizophrenia in adults were effective at treating the disorders in children and adolescents, but carry significant risks.” The FDA is now “considering applications (pdf) for [...]
Health Canada Approves Ziprasidone Hydrochloride for Bipolar Disorder
Thursday, February 12th, 2009Health Canada has approved ziprasidone hydrochloride (Geodon/Zeldox) for the treatment of acute manic or mixed episodes associated with bipolar disorder.
“As many bipolar disorder medications cause substantial weight gain, it is often challenging to treat patients for this serious and often disabling condition,” said Roger McIntyre, MD, Mood Disorders Psychopharmacology Unit, University Health Network, and University [...]
